David L. Hayes Expands Snell & Wilmer's Life Sciences and Medical Technology Group

ORANGE COUNTY, Calif. - Dec. 12, 2017 - PRLog -- Snell & Wilmer is pleased to announce that David L. Hayes has joined the firm as Of Counsel in the life sciences and medical technology group.

Prior to joining Snell & Wilmer, Hayes served as the general counsel for two medical device companies, NeuroSigma, Inc., a neuromodulation med device company, and NSVascular, Inc., a medical device company developing thin-film nitinol stents for neurovascular brain aneurysms. While there, Hayes was responsible for counseling the company in key strategic areas, including corporate governance, technology license agreements, strategic collaborations, joint ventures, manufacturing agreements and commercialization agreements and led the company's negotiations on complex licensing, strategic partnering transactions and financings, including the preparation for an IPO.

"David is an exceptional corporate attorney with extensive and broad experience in the life sciences industry," said Ketan Vakil, administrative partner of Snell & Wilmer's Orange County office. "David's unique background will add depth and strengthen to Snell & Wilmer's existing life sciences and medical devices technology group."

David's industry experience covers a wide variety of areas including life science, pharma, biotech, medical devices, computer hardware, semiconductors, software and information technology and outsourcing, among others. His practice included domestic and international transactions that focus on the entire intellectual property life cycle including, acquisition of intellectual property assets, research and development, sale and distribution of intellectual property assets, patent, copyright and trademark licensing, outsourcing and facilities management, strategic alliances, biotechnology research and development, computer services and software and hardware development.

Hayes also advised clients on co-promotion, distribution, technology-related professional services, semiconductor supply, system integration, software and hardware maintenance and disaster recovery. His work includes mergers and acquisitions involving life science and technology targets. He assists clients with intellectual property protection programs and copyright and trademark registration prosecution.

Prior to practicing law, Hayes was a computer programmer and software engineer for a major utility company where his responsibilities included research into various state-of-the-art technologies. This background is extremely valuable in connection with technology related transactions.

Hayes earned his B.A. cum laude from the University of California, Irvine and his J.D. cum laude from Cornell Law School.

For more information about David's practice, visit www.swlaw.com/people/david_hayes.

About Snell & Wilmer's Life Sciences and Medical Technology Practice
Snell & Wilmer's life sciences and medical technology lawyers currently represent a diverse client base from the bioscience, pharmaceutical (both prescription and OTC), medical device and healthcare industries, ranging from large publicly-traded organizations to early and mid-stage start-up companies.

Clients turn to Snell & Wilmer when structuring and completing the sale or acquisition of their business or specific IP assets, capital raising, licensing, or engaging third parties to research, develop, test, manufacture, distribute and/or sell their products and services. Additionally, clients rely on Snell & Wilmer's life sciences and medical technology attorneys to protect their intellectual property assets and to proactively strategize on R&D and commercialization approaches that maximize the scope of their IP protection. The firm has a proven track record representing manufacturers, distributors, inventors, researchers, universities, venture capitalists, angel investors, engineers, product designers and vendors, whose products and services span the fields of bioengineering and medical device development, biologics including genomics and proteomics-based therapies, bioinformatics, diagnostics, drug delivery and formulation chemistries, health information technologies and health economics, medical device, microbiology and virology, nanotechnology and pharmaceutical small molecule therapeutics.

About Snell & Wilmer
Founded in 1938, Snell & Wilmer is a full-service business law firm with more than 400 attorneys practicing in nine locations throughout the western United States and in Mexico, including Orange County and Los Angeles, California; Phoenix and Tucson, Arizona; Denver, Colorado; Las Vegas and Reno, Nevada; Salt Lake City, Utah; and Los Cabos, Mexico. The firm represents clients ranging from large, publicly traded corporations to small businesses, individuals and entrepreneurs. For more information, visit www.swlaw.com.